NASDAQ: BGNE - BeiGene, Ltd.

Yield per half year: +17.66%
Dividend yield: 0.00%
Sector: Healthcare

Current price
184.71 $
Average price
133.03 $ -27.98%

Price based on EPS
188.31 $ +1.95%
Discount price Net Income
77.74 $ -57.91%
5/10

Price based on EPS

Price = Price * (100 - CAGR EPS * Excess Key Rate) / 100
Key Rate = Key rate
Fair price = 188.31 $
Current price = 184.71 $ (difference = +1.95%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -110.72 $
Current price = 184.71 $ (difference = -159.94%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -1 971.39 $
Current price = 184.71 $ (difference = -1 167.29%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription